• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部肿瘤学中功能性患者报告结局的有效性:系统评价。

Validity of functional patient-reported outcomes in head and neck oncology: A systematic review.

机构信息

Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, 8440 112(th) Street Northwest, Edmonton, Alberta T6G 2R7, Canada; Division of Head and Neck Oncology and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Schulich School of Medicine and Dentistry, University of Western Ontario, 1151 Richmond Street, London, Ontario N6A 3K7, Canada.

Division of Head and Neck Oncology and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Schulich School of Medicine and Dentistry, University of Western Ontario, 1151 Richmond Street, London, Ontario N6A 3K7, Canada.

出版信息

Oral Oncol. 2022 Feb;125:105701. doi: 10.1016/j.oraloncology.2021.105701. Epub 2022 Jan 10.

DOI:10.1016/j.oraloncology.2021.105701
PMID:35021152
Abstract

Malignancy and treatment effects in head and neck oncology can be devastating to functional aspects of patient life such as swallowing, blinking, speech, salivation, and facial expression. Historically, the subjective nature of patient experience has resulted in difficulty with quantification and measurement of functional outcomes. Patient-Reported Outcomes (PROs) are questionnaires developed with patient input, forming the new gold standard for clinician assessment of subjective functional outcomes. The current review aims to identify and characterize the validation of PROs pertaining to four critical functional outcomes in head and neck oncology: swallowing, speech, dry mouth, and chewing. A literature search was conducted using MEDLINE, EMBASE, and the Cochrane databases for published, English language, peer-reviewed abstracts involving patients ≥ 18 years of age. Of 708 results, 705 were excluded at abstract or full text screening for not meeting inclusion criteria, exclusion of head and neck SCC patients in development, or absence of a functional domain measurement. The three reviewed studies-Xerostomia Questionnaire, Swallowing Outcomes After Laryngectomy, and Edmonton 33-exhibited strong reliability and construct and content validity, though two applied only to individual functional outcomes within specific patient populations receiving radiation or laryngectomy. While many PROs have been developed in head and neck oncology, very few properly employed extensive patient input in the development process. Further work must be committed to increasing head and neck cancer patient input in PRO development, particularly in the functional domains of speech and chewing.

摘要

头颈部肿瘤的恶性肿瘤和治疗效果可能会对患者生活的功能方面造成严重影响,例如吞咽、眨眼、言语、唾液分泌和面部表情。从历史上看,患者体验的主观性导致功能结果的量化和测量存在困难。患者报告的结果(PROs)是在患者的投入下开发的问卷,成为评估主观功能结果的临床医生的新标准。本综述旨在确定和描述与头颈部肿瘤的四个关键功能结果(吞咽、言语、口干和咀嚼)相关的 PRO 的验证。使用 MEDLINE、EMBASE 和 Cochrane 数据库进行文献检索,以查找涉及≥18 岁患者的已发表的英文同行评审摘要。在 708 项结果中,有 705 项在摘要或全文筛选时被排除,原因是不符合纳入标准、开发过程中排除头颈部 SCC 患者或缺乏功能域测量。综述的三项研究——口干问卷、喉切除术的吞咽结果和埃德蒙顿 33 项——表现出很强的可靠性以及结构和内容有效性,尽管其中两项仅适用于接受放疗或喉切除术的特定患者群体中的个别功能结果。尽管在头颈部肿瘤学中已经开发了许多 PRO,但很少有研究在开发过程中充分利用患者的广泛投入。必须进一步努力增加头颈部癌症患者在 PRO 开发中的投入,特别是在言语和咀嚼的功能领域。

相似文献

1
Validity of functional patient-reported outcomes in head and neck oncology: A systematic review.头颈部肿瘤学中功能性患者报告结局的有效性:系统评价。
Oral Oncol. 2022 Feb;125:105701. doi: 10.1016/j.oraloncology.2021.105701. Epub 2022 Jan 10.
2
Screening for speech and language delay in preschool children: systematic evidence review for the US Preventive Services Task Force.学龄前儿童言语和语言发育迟缓筛查:美国预防服务工作组的系统证据综述
Pediatrics. 2006 Feb;117(2):e298-319. doi: 10.1542/peds.2005-1467.
3
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
8
Music interventions for improving psychological and physical outcomes in people with cancer.音乐干预对改善癌症患者心理和生理结局的影响。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4.
9
Oxycodone for cancer-related pain.羟考酮治疗癌性疼痛。
Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD003870. doi: 10.1002/14651858.CD003870.pub7.
10
Botulinum toxin type B for cervical dystonia.用于治疗颈部肌张力障碍的B型肉毒毒素
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004315. doi: 10.1002/14651858.CD004315.pub2.

引用本文的文献

1
Psychometric validation of the Chinese version of the Edmonton-33 scale in patients with head and neck cancer.埃德蒙顿-33量表中文版在头颈癌患者中的心理测量学验证
Asia Pac J Oncol Nurs. 2025 Mar 8;12:100685. doi: 10.1016/j.apjon.2025.100685. eCollection 2025 Dec.
2
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy.头颈部癌症放疗后长期生存患者报告的晚期效应与全身细胞因子之间的关系。
J Cancer Surviv. 2023 Aug;17(4):1082-1093. doi: 10.1007/s11764-022-01273-1. Epub 2022 Nov 9.